216 related articles for article (PubMed ID: 2474830)
21. Hepatitis B virus core antigen: enhancement of its production in Escherichia coli, and interaction of the core particles with the viral surface antigen.
Tan WS; Dyson MR; Murray K
Biol Chem; 2003 Mar; 384(3):363-71. PubMed ID: 12715887
[TBL] [Abstract][Full Text] [Related]
22. Expression of the core antigen gene of hepatitis B virus (HBV) in Acetobacter methanolicus using broad-host-range vectors.
Schröder R; Maassen A; Lippoldt A; Börner T; von Baehr R; Dobrowolski P
Appl Microbiol Biotechnol; 1991 Aug; 35(5):631-7. PubMed ID: 1367579
[TBL] [Abstract][Full Text] [Related]
23. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.
Hosono S; Tai PC; Wang W; Ambrose M; Hwang DG; Yuan TT; Peng BH; Yang CS; Lee CS; Shih C
Virology; 1995 Sep; 212(1):151-62. PubMed ID: 7545853
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
25. Expression in Escherichia coli of a cloned DNA sequence encoding the pre-S2 region of hepatitis B virus.
Offensperger W; Wahl S; Neurath AR; Price P; Strick N; Kent SB; Christman JK; Acs G
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7540-4. PubMed ID: 2415963
[TBL] [Abstract][Full Text] [Related]
26. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
27. [Structure and expression in Escherichia coli cells of the core antigen gene of the human hepatitis B virus (HBV)].
Borisova GP; Pumpen PP; Bychko VV; Pushko PM; Kalis IaV
Dokl Akad Nauk SSSR; 1984; 279(5):1245-9. PubMed ID: 6394254
[No Abstract] [Full Text] [Related]
28. Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties.
Beesley KM; Francis MJ; Clarke BE; Beesley JE; Dopping-Hepenstal PJ; Clare JJ; Brown F; Romanos MA
Biotechnology (N Y); 1990 Jul; 8(7):644-9. PubMed ID: 1369994
[TBL] [Abstract][Full Text] [Related]
29. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
30. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E
Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334
[TBL] [Abstract][Full Text] [Related]
31. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
Kuhöber A; Pudollek HP; Reifenberg K; Chisari FV; Schlicht HJ; Reimann J; Schirmbeck R
J Immunol; 1996 May; 156(10):3687-95. PubMed ID: 8621903
[TBL] [Abstract][Full Text] [Related]
32. Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein.
Tarar MR; Emery VC; Harrison TJ
FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):183-92. PubMed ID: 9116635
[TBL] [Abstract][Full Text] [Related]
33. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
[TBL] [Abstract][Full Text] [Related]
34. [Introduction of heterologous epitopes at the N-terminal part of the hepatitis B core protein].
Kalinina TI; Makeeva IV; Khudiakov IuE; Samoshin VV; Smirnova EA; Semiletov IuA; Pavliuchenkova RP; Kadoshnikov IuP; Smirnov VD
Mol Biol (Mosk); 1995; 29(1):199-210. PubMed ID: 7723760
[TBL] [Abstract][Full Text] [Related]
35. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice.
Tindle RW; Herd K; Londoño P; Fernando GJ; Chatfield SN; Malcolm K; Dougan G
Virology; 1994 May; 200(2):547-57. PubMed ID: 7513919
[TBL] [Abstract][Full Text] [Related]
36. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
[TBL] [Abstract][Full Text] [Related]
37. Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core protein.
Yoshikawa A; Tanaka T; Hoshi Y; Kato N; Tachibana K; Iizuka H; Machida A; Okamoto H; Yamasaki M; Miyakawa Y
J Virol; 1993 Oct; 67(10):6064-70. PubMed ID: 8396669
[TBL] [Abstract][Full Text] [Related]
38. [Antigenic analysis of two chimeric hepatitis B core particles presenting the preS1 neutralizing epitopes].
Su QD; Guo MZ; Yi Y; Chen SY; Jia ZY; Lu XX; Qiu F; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):336-9. PubMed ID: 24645316
[TBL] [Abstract][Full Text] [Related]
39. Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope.
Kazaks A; Balmaks R; Voronkova T; Ose V; Pumpens P
Biotechnol J; 2008 Nov; 3(11):1429-36. PubMed ID: 18956370
[TBL] [Abstract][Full Text] [Related]
40. [Cloning and expression of the gene coding the hepatitis B virus surface antigen (HBsAg) in Escherichia coli].
Lunin VG; Gol'dberg EZ; Grigor'ev VG; Mikhaĭlov MM; Khudiakov IuE
Dokl Akad Nauk SSSR; 1983; 268(2):496-8. PubMed ID: 6339184
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
